In this blog, I would like to honestly and comprehensively review my first year of clinical use of exosomes.
A video of the lecture I gave at the University of Hawaii, featuring some of my actual patients discussing their improvements.
It appears that the benefits of tendon injection are gradual and continuous and are better at four weeks than at two weeks
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness
